In Hong Kong, the first case of a patient who died after being vaccinated with a BioNTech drug purchased in Germany is being investigated. This was reported today, March 19, by the radio station RTHK.
The 66-year-old local man received his first dose of the vaccine last Tuesday and has not complained of any ailments since, even though he has a history of diabetes and several other chronic diseases.
Previously, seven deaths had been reported in Hong Kong following vaccination with a drug from Chinese manufacturer Sinovac. However, government experts believe that there is no direct link between the use of the drug and the deaths of elderly patients with chronic diseases.
As reported by EADaily, a free and voluntary vaccination program in Hong Kong was launched on February 26. During this time, the first dose of Sinovac and BioNTech vaccines was given to almost 300,000 residents.
The latest data on fatal outcomes after vaccination with this American-German vaccine are recorded in Austria – after receiving a vaccine from Pfizer and BioNTech 41 people died there. However, authorities are not inclined to draw unequivocal conclusions and declare “an ongoing investigation of the causes.